[HTML][HTML] The emergence, genomic diversity and global spread of SARS-CoV-2

J Li, S Lai, GF Gao, W Shi - Nature, 2021 - nature.com
Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has
witnessed a devastating global pandemic, with more than 238 million cases, nearly 5 million …

[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights

T Carvalho, F Krammer, A Iwasaki - Nature Reviews Immunology, 2021 - nature.com
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …

[HTML][HTML] Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron

H Shuai, JFW Chan, B Hu, Y Chai, TTT Yuen, F Yin… - Nature, 2022 - nature.com
Abstract The Omicron (B. 1.1. 529) variant of SARS-CoV-2 emerged in November 2021 and
is rapidly spreading among the human population. Although recent reports reveal that the …

Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients

L Lu, BWY Mok, LL Chen, JMC Chan… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron
variant, designated as a variant of concern by the World Health Organization, carries …

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

H Zhao, L Lu, Z Peng, LL Chen, X Meng… - Emerging microbes & …, 2022 - Taylor & Francis
ABSTRACT The novel SARS-CoV-2 Omicron variant (B. 1.1. 529), first found in early
November 2021, has sparked considerable global concern and it has> 50 mutations, many …

[HTML][HTML] COVID-19: breaking down a global health crisis

SI Mallah, OK Ghorab… - Annals of …, 2021 - ann-clinmicrob.biomedcentral.com
Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first century,
with over one-hundred million infections and over two million deaths to date. It is a novel …

COVID-19: a global challenge with old history, epidemiology and progress so far

M Khan, SF Adil, HZ Alkhathlan, MN Tahir, S Saif… - Molecules, 2020 - mdpi.com
Humans have witnessed three deadly pandemics so far in the twenty-first century which are
associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and …

[HTML][HTML] COVID-19 in early 2021: current status and looking forward

C Wang, Z Wang, G Wang, JYN Lau… - Signal Transduction and …, 2021 - nature.com
Since the first description of a coronavirus-related pneumonia outbreak in December 2019,
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …

Nurses' burnout and associated risk factors during the COVID‐19 pandemic: A systematic review and meta‐analysis

P Galanis, I Vraka, D Fragkou, A Bilali… - Journal of advanced …, 2021 - Wiley Online Library
Aims To examine the nurses' burnout and associated risk factors during the COVID‐19
pandemic. Design We followed the Cochrane criteria and the Preferred Reporting Items for …

COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention

A Sharma, I Ahmad Farouk, SK Lal - Viruses, 2021 - mdpi.com
Three major outbreaks of the coronavirus, a zoonotic virus known to cause respiratory
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …